Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - January 2014

Social Media in the Pharmaceutical Industry

22 Jan 2014 - 23 Jan 2014 - London, UK

Bookmark and Share

SMi is pleased to present the 6th instalment in the sell out Social Media Pharmaceutical conference series which returns to London on 22nd and 23rd January 2014.

With health at the top of any patient’s agenda the opportunity for health professionals to utilise social media to provide personalised care is abundant and with mobile devices becoming increasingly prolific, this personal contact is fast becoming continuous. Media is no longer simply a tool for companies to broadcast their own message, but has transformed into a means in which pharma are able to provide round the clock care, through active monitoring and remote diagnosis.

Join our panel of leading industry speakers, from Big Pharma companies to cutting edge developers at the heart of social media technology today. You simply cannot afford to miss out.

Reasons to Attend:

Learn about the cutting edge developments in social media including personalised marketing techniques, mobile platforms, remote monitoring and open stakeholder engagement.

Share ideas with leading technology providers; discuss the industry requirements and learn what technological solutions are available.

Hear how major pharmaceutical companies are actually applying the latest developments in social media in a practical way.

Analyse how social media will allow your organisation to better communicate and interact with your stakeholders.

Expert Speaker Line-up includes:

Doris Cesares, Director of Communication, AESEG

Sherri Matis-Mitchell, R and D, Astra Zeneca 

Neeraj Goel Mittal, Business Intelligence Manager, AbbVie 

Dr. Alfred R. Steinhardt, Founder, Alfred Steinhardt Consulting

Piotr Wrzosinski, Digital Marketing, Roche 

Ben Furber, Asthma UK

Claire Perrin, European Brand Leader, Eli Lilly

Alexandra Fulford, Consultant, Pharmaguapa 

Gizem Bicakci, eMarketing, Boehringer-Ingelheim 

Matt Evans, Chief Medical Officer, Health Unlocked 

Todd Kolm, Vice-President, Head of Global Digital Strategy, Sanofi

James Finney, Project Manager, Global Comm. Services, Novozymes Biopharma

Shona Davies, Communication and Programme Leader, Merck

For further details and to register, visit 

Alternatively contact John Collins on +44 (0)20 7827 6000 or email 

Join the conversation on Twitter @smigrouppharm | #pharmasocialmedia

Further information
Scientific News
Drug May Prevent Life-Threatening Muscle Loss in Advanced Cancers
New data describes how an experimental drug can stop life-threatening muscle wasting (cachexia) associated with advanced cancers and restore muscle health.
Chemical Design Made Easier
Rice University scientists prepare elusive organocatalysts for drug and fine chemical synthesis.
Nanocarriers May Carry New Hope for Brain Cancer Therapy
Berkeley lab researchers develop nanoparticles that can carry therapeutics across the brain blood barrier.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Fighting Pain with Ketamine
Researchers at the Texas A&M Health Science Center are using ketamine, a drug that already exists as an anesthetic, to treat pain.
Possible New Treatment for Neurodegenerative Diseases Found
Researchers at the University of Liverpool have found that a well-established anti-epileptic drug could also be used as a treatment for neurodegenerative diseases.
Breast Cancer Drug Beats Superbug
Tamoxifen helps white blood cells clear multidrug-resistant bacteria in lab and mouse studies.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos